Deep learning convolutional neural network ResNet101 and radiomic features accurately analyzes mpMRI imaging to predict MGMT promoter methylation status with transfer learning approach

Documenti analoghi

• mpMRI‐based MGMT methylation status prediction for glioblastoma through off‐the‐shelf deep features: A multi‐dataset feasibility study
  di: Junhua Chen, et al.
  Pubblicazione: (2025)
• Enhancing Prostate Cancer Diagnosis: The Combined Value of PHI and mpMRI
  di: Y. M. Yáñez‐Castillo, et al.
  Pubblicazione: (2025)
• Texture Feature Analysis for Classification of Early-Stage Prostate Cancer in mpMRI
  di: Muftah, Asmail, et al.
  Pubblicazione: (2024)
• Comparative Analysis of 2D and 3D ResNet Architectures for IDH and MGMT Mutation Detection in Glioma Patients
  di: Elyassirad, Danial, et al.
  Pubblicazione: (2024)
• Reliability of mpMRI in diagnosing cancer prostate following intravesical BCG for bladder cancer
  di: Arjun Pon Avudaiappan, et al.
  Pubblicazione: (2024)